Drug Free Solution, Inc.
DSOL
$0.00
-$0.09-98.76%
OTC PK
| 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | 02/28/2013 | |
|---|---|---|---|---|---|
| Net Income | 3.68% | -147.33% | 91.17% | -635.08% | 399.44% |
| Total Depreciation and Amortization | 133.33% | 650.00% | 150.00% | -144.44% | 350.00% |
| Total Amortization of Deferred Charges | 50.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -78.63% | 1,135.85% | -87.41% | 105.37% | -- |
| Cash from Operations | -77.64% | -28.51% | 91.53% | -513.33% | 461.41% |
| Capital Expenditure | 100.00% | -- | -- | 200.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | 200.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -200.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.84% | 150.91% | -92.25% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.84% | 150.91% | -92.25% | 673.13% | -377.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 690.91% | 82.81% | 74.50% | -175.60% | 872.09% |